Literature DB >> 4207759

Relationship between the uptake of isoniazid and its action on in vivo mycolic acid synthesis in Mycobacterium tuberculosis.

L Wang, K Takayama.   

Abstract

A direct relationship was established between the rate of uptake of isoniazid and the action of this drug on in vivo mycolic acid synthesis in Mycobacterium tuberculosis H37Ra. The rate of uptake of isoniazid increased linearly with its external concentration and appeared to reach a maximal value of 52 pmoles per hr per 10(9) cells at an external concentration of about 13 mum. Correspondingly, the rate of inhibition of mycolic acid synthesis increased with the rise in the rate of uptake of the drug. A 50% inhibition of mycolic acid synthesis occurred when the uptake of isoniazid reached 5.2 pmoles per 10(9) cells. Calculations showed that this level of drug uptake represents an internal cellular concentration of 9 mum. These results show clearly that the action of isoniazid on the mycolate synthetase system of M. tuberculosis is rapid and that this enzyme system is highly sensitive to the drug.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4207759      PMCID: PMC444336          DOI: 10.1128/AAC.2.6.438

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  8 in total

1.  Selective inhibition of nucleic acid synthesis in Mycobacterium tuberculosis by isoniazid.

Authors:  P R GANGADHARAM; F M HAROLD; W B SCHAEFER
Journal:  Nature       Date:  1963-05-18       Impact factor: 49.962

Review 2.  Intermediary metabolism of mycobacteria.

Authors:  T Ramakrishnan; P S Murthy; K P Gopinathan
Journal:  Bacteriol Rev       Date:  1972-03

3.  Inhibition by isoniazid of synthesis of mycolic acids in Mycobacterium tuberculosis.

Authors:  F G Winder; P B Collins
Journal:  J Gen Microbiol       Date:  1970-09

4.  Susceptibility of mycobacterial D-alanyl-D-alanine synthetase to D-cycloserine.

Authors:  H L David; K Takayama; D S Goldman
Journal:  Am Rev Respir Dis       Date:  1969-10

5.  Chemotherapy of experimental tuberculosis. V. Isonicotinic acid hydrazide (nydrazid) and related compounds.

Authors:  J BERNSTEIN; W A LOTT; B A STEINBERG; H L YALE
Journal:  Am Rev Tuberc       Date:  1952-04

6.  Effect of isoniazid on the in vivo mycolic acid synthesis, cell growth, and viability of Mycobacterium tuberculosis.

Authors:  K Takayama; L Wang; H L David
Journal:  Antimicrob Agents Chemother       Date:  1972-07       Impact factor: 5.191

7.  Mechanism of Action of Isoniazid on Mycobacterium bovis Strain BCG.

Authors:  J K McClatchy
Journal:  Infect Immun       Date:  1971-04       Impact factor: 3.441

8.  Isoniazid uptake in relation to growth inhibition of Mycobacterium tuberculosis.

Authors:  W H Beggs; J W Jenne; W H Hall
Journal:  J Bacteriol       Date:  1968-08       Impact factor: 3.490

  8 in total
  9 in total

1.  Antimycobacterial activities of isoxyl and new derivatives through the inhibition of mycolic acid synthesis.

Authors:  B Phetsuksiri; A R Baulard; A M Cooper; D E Minnikin; J D Douglas; G S Besra; P J Brennan
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

Review 2.  Tuberculosis Drug Development: History and Evolution of the Mechanism-Based Paradigm.

Authors:  Sumit Chakraborty; Kyu Y Rhee
Journal:  Cold Spring Harb Perspect Med       Date:  2015-04-15       Impact factor: 6.915

Review 3.  Mycobacterium.

Authors:  L Barksdale; K S Kim
Journal:  Bacteriol Rev       Date:  1977-03

4.  Metabolic role of free mycolic acids in Mycobacterium tuberculosis.

Authors:  K Takayama; E L Armstrong
Journal:  J Bacteriol       Date:  1977-04       Impact factor: 3.490

5.  Enumeration of tubercle bacilli in sputum of patients with pulmonary tuberculosis.

Authors:  G L Hobby; A P Holman; M D Iseman; J M Jones
Journal:  Antimicrob Agents Chemother       Date:  1973-08       Impact factor: 5.191

6.  Identification of a nicotinamide adenine dinucleotide glycohydrolase and an associated inhibitor in isoniazid-susceptible and -resistant Mycobacterium phlei.

Authors:  W B Davis
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

7.  Scanning electron microscopy of the H37Ra strain of Mycobacterium tuberculosis exposed to isoniazid.

Authors:  K Takayama; L Wang; R S Merkal
Journal:  Antimicrob Agents Chemother       Date:  1973-07       Impact factor: 5.191

8.  Arylamine N-acetyltransferase is required for synthesis of mycolic acids and complex lipids in Mycobacterium bovis BCG and represents a novel drug target.

Authors:  Sanjib Bhakta; Gurdyal S Besra; Anna M Upton; Tanya Parish; Carolyn Sholto-Douglas-Vernon; Kevin J C Gibson; Stuart Knutton; Siamon Gordon; Rosangela P DaSilva; Matthew C Anderton; Edith Sim
Journal:  J Exp Med       Date:  2004-04-26       Impact factor: 14.307

9.  Isoniazid Killing of Mycobacterium smegmatis NADH Pyrophosphatase Mutant at Single-Cell Level using Microfluidics and Time-Lapse Microscopy.

Authors:  Meltem Elitas
Journal:  Sci Rep       Date:  2017-09-07       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.